The short answer
RIVACTA's first priority is Korean medical-beauty providers ready to serve Japanese patients; the second is established K-beauty brands with viable Japan unit economics. Japanese beauty, consumer, and food brands entering Korea are a selective third priority when local ownership and operating budgets are confirmed. High category ad spend alone does not prove an individual company can fund or benefit from a cross-border partner.
Industries with the largest money flows are not automatically the companies most able to pay RIVACTA. Strong demand can still destroy value when margins, compliance, logistics, consultation, or customer support are not ready.
We score market demand, customer value or contribution margin, need for an external partner, measurability, operational readiness, and RIVACTA delivery fit separately. The ranking below is RIVACTA's inference from public evidence, not an official market ranking.
What are the 2026 execution priorities?
Korea received more than 2.01 million foreign patients in 2025, while Japanese visitors recorded KRW 279.6 billion in medical-category card spending in 2024. Korean cosmetics exports also reached a record in 2025. These are strong demand signals, but readiness and economics decide whether to launch.
| Priority | Target | Money-flow signal | Launch gate |
|---|---|---|---|
| P0 | Korean medical beauty ready for Japanese patients | High customer value and measurable consultation-to-visit journey | Patient-acquisition process, Japanese consultation, aftercare, compliance owner |
| P1 | K-beauty entering Japan | Export growth and repeat-purchase potential | Claims, supply, post-return margin, Japanese CS, channel data |
| Selective P2 | Japanese beauty, consumer, and food brands entering Korea | Growing trade and investment signals | Korea owner, regulatory and distribution budgets, inventory and CS |
| Watch | K-food, franchises, IP | Opportunity with uneven margin and distribution structures | Project-by-project diagnostic |
| Deprioritize | Gaming, fintech, manufacturing, enterprise procurement | Large markets or ad budgets may exist | Poor fit with current scope and sales cycle |
How do we verify ability to pay?
Revenue and industry ad-spend averages are insufficient. Verify seven separate budgets: paid diagnostic, partner fee, media, localization and production, compliance and specialists, logistics/inventory/returns or patient operations, and internal staff or customer support.
- Can fund execution dependencies separately from the partner fee
- Has a CAC ceiling based on contribution margin after returns and fees
- Can track a consultation, booking, sale, or repeat purchase within 90 days
- Has named owners for compliance, CS, inventory, or aftercare
Why does high ad spend not equal a good client?
Food and cosmetics have large shares of Japan's advertising market, and internet ad spend exceeded JPY 4 trillion. That shows category intensity, not a specific buyer's readiness. If the seven budgets and operating owners cannot be verified in discovery, a paid diagnostic or a hold is more suitable than a managed engagement.
Frequently asked questions
Should we prospect the industries with the biggest ad budgets first?
No. Category ad spend is a demand signal. Verify contribution margin, partner need, operational readiness, and measurement at account level.
Which budgets matter before a managed engagement?
In addition to the partner fee, verify media, production, compliance, logistics or patient operations, customer support, and internal staffing.
Is an unready company a bad lead?
It may be too early for managed execution but suitable for a paid diagnostic that can result in launch, remediation, or a hold.